CBIO - GLYCOMIMETICS INC
12.07
0.740 6.131%
Share volume: 159,573
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$11.33
0.74
0.07%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-13-2024 | 02-13-2025 | 05-14-2025 | 07-31-2025 | 11-06-2025 | 02-26-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 10.844 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 10.844 M | |
| nan% | nan% | nan% | nan% | nan% | inf% | ||||
| Operating expenses | 11.115 M | 10.358 M | 5.721 M | 5.315 M | 2.399 M | 21.030 M | 25.885 M | 114.162 M | |
| Selling general and admin | 5.090 M | 4.072 M | 4.006 M | 5.082 M | 2.384 M | 8.949 M | 5.538 M | 8.519 M | |
| Research and development | 6.025 M | 6.286 M | 1.715 M | 233.214 K | 14.776 K | 12.081 M | 20.347 M | 105.643 M | |
| Total expenses | 11.115 M | 10.358 M | 11.234 M | 7.333 M | 2.399 M | 21.030 M | 25.885 M | 114.162 M | |
| -6.81% | 8.46% | -34.73% | -67.29% | 776.66% | 23.09% | 341.04% | |||
| Operating income | -11.115 M | -10.358 M | -11.234 M | -7.333 M | -2.399 M | -21.030 M | -25.885 M | -103.318 M | |
| Ebit | -11.115 M | -10.358 M | -10.009 M | -7.333 M | -2.399 M | -21.030 M | -25.885 M | -103.318 M | |
| Pretax income | -10.737 M | -10.095 M | -9.824 M | -7.223 M | -2.344 M | -21.790 M | -24.607 M | -103.201 M | |
| -5.97% | -2.69% | -26.48% | -67.55% | 829.71% | 12.93% | 319.40% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -10.737 M | -10.095 M | -9.824 M | -7.223 M | -2.344 M | -21.790 M | -24.607 M | -105.201 M | |
| 5.97% | 2.69% | 26.48% | 67.55% | -829.71% | -12.93% | -327.53% |